A ternary solid solution (0.935‐x)Bi0.5Na0.5TiO3–0.065BaTiO3–xSrTiO3 was designed and fabricated using a conventional fabrication process. Temperature and composition dependence of the ferroelectric, dielectric, and piezoelectric properties were systematically investigated and a schematic phase diagram was established. The SrTiO3 substitution was found to induce a transition from ferroelectric to relaxor pseudocubic phases. Around a critical composition x of 0.22, large strain response of ~0.2% (under a moderate field of 4 kV/mm) with normalized strain of 490 pm/V was obtained. The large unipolar strain response would be of great interest for environmental‐friendly “on‐off” actuators.
In this work, an electric field-induced giant strain response and excellent photoluminescence-enhancement effect was obtained in a rare-earth ion modified lead-free piezoelectric system. Pr(3+)-modified 0.93(Bi0.5Na0.5)TiO3-0.07BaTiO3 ceramics were designed and fabricated by a conventional fabrication process. The ferroelectric, dielectric, piezoelectric, and photoluminescence performances were systematically studied, and a schematic phase diagram was constructed. It was found the Pr(3+) substitution induced a transition from ferroelectric a long-range order structure to a relaxor pseudocubic phase with short-range coherence structure. Around a critical composition of 0.8 mol % Pr(3+), a giant reversible strain of ∼0.43% with a normalized strain Smax/Emax of up to 770 pm/V was obtained at ∼5 kV/mm. Furthermore, the in situ electric field enhanced the photoluminescence intensity by ∼40% in the proposed system. These findings have great potential for actuator and multifunctional device applications, which may also open up a range of new applications.
Bifidobacteria
are considered one of the most important intestinal probiotics because of their significant health impact. However, this ability is usually limited by gastrointestinal fluid and temperature sensitivity. Emulsification and internal gelation is an encapsulation technique with great potential for probiotic protection during storage and the gastrointestinal transit process. This study prepared microcapsules using an emulsification and internal gelation encapsulation method with sodium alginate, chitosan, and
Bifidobacterium longum
as wall material, coating material, and experimental strain, respectively. Optical, scanning electron, and focal microscopes were used to observe the microcapsule surface morphology and internal viable cell distribution, and a laser particle size analyzer and zeta potentiometer were used to evaluate the chitosan-coating characteristics. In addition, microcapsule probiotic viability after storage, heat treatment, and simulated gastrointestinal fluid treatment were examined. Alginate microcapsules and chitosan-coated alginate microcapsules both had balling properties and uniform bacterial distribution. The latter kept its balling properties after freeze-drying, verified by scanning electronic microscopy (SEM), and had a clear external coating, observed by an optical microscope. The particle size of chitosan-coated alginate microcapsules was slightly larger than the uncoated microcapsules. The zeta potential of alginate and chitosan-coated alginate microcapsules was negative and positive, respectively. Heat, acid and bile salt tolerance, and stability tests revealed that the decrease of viable cells in the chitosan-coated alginate microcapsule group was significantly lower than that in uncoated microcapsules. These experimental results indicate that the chitosan-coated alginate microcapsules protect
B. longum
from gastrointestinal fluid and high-temperature conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.